Zobrazeno 1 - 10
of 16
pro vyhledávání: '"J. S. Greengard"'
Autor:
P H Reitsma, F Bernardi, R G Doig, S Gandrille, J S Greengard, H Ireland, M Krawczak, B Lind, G L Long, S R Poort, H Saito, N Sala, I Witt, D N Cooper
Publikováno v:
Thrombosis and Haemostasis. 73:876-889
Autor:
W. Tsay, J. S. Greengard, R. R. Montgomery, R. A. McPherson, J. C. Fucci, M. A. Koerper, J. Coughlin, J. H. Griffin
Publikováno v:
Blood Coagulation & Fibrinolysis. 4:791-796
Autor:
J S, Greengard
Publikováno v:
IDrugs : the investigational drugs journal. 2(2)
The annual meeting of the American Society of Hematology was attended by over 30,000 researchers, nurses, hematologists and physicians. The work presented covered a spectrum from basic science, drugs in development and reports of clinical trials. Ove
Autor:
J S, Greengard, D J, Jolly
Publikováno v:
Thrombosis and haemostasis. 82(2)
Publikováno v:
Thrombosis and haemostasis. 75(1)
cDNAs for protein C inhibitor (PCI), prepared from human liver RNA, contained two forms of PCI, designated PCI*A and PCI*B. While PCI*A is identical to the published PCI sequence, PCI*B differs in 4 of 1221 bp and two amino acids, A36V and K86E. Freq
Publikováno v:
Thrombosis and haemostasis. 74(4)
cDNAs for protein C inhibitor (PCI) were cloned from human and rhesus monkey liver RNAs by reverse transcription and polymerase chain reaction (PCR) amplification. Sequencing showed that rhesus monkey and human PCI cDNAs were 93% identical. Predicted
Activated protein C resistance: molecular mechanisms based on studies using purified Gln506-factor V
Publikováno v:
Blood. 85(12)
Gln506-factor V (FV) was purified from plasma of an individual homozygous for an Arg506Gln mutation in FV that is associated with activated protein C (APC) resistance. Purified Gln506-FV, as well as Gln506-FVa generated by either thrombin or FXa, con
Autor:
P H, Reitsma, F, Bernardi, R G, Doig, S, Gandrille, J S, Greengard, H, Ireland, M, Krawczak, B, Lind, G L, Long, S R, Poort
Publikováno v:
Thrombosis and haemostasis. 73(5)
Publikováno v:
Blood. 85(7)
The original activated partial thromboplastin time-based assay for activated protein C (APC)-resistant factor Va (FVa) requires carefully prepared fresh plasma and cannot be used in patients receiving warfarin or in patients with antiphospholipid ant
Publikováno v:
The New England journal of medicine. 331(23)